Enhanced expression of ACE in CD115+ myelomonocytic cells (ACE10 or ACE10/10 model) improve their ability to mediate an effective immune response to remove viral and bacterial infections, cancer growth, and atherosclerotic plaques (Shen et al., 2007; Okwan-Duodu et al., 2010). This evidence concerns the gene CSF1R and bacterial infectious disease.